Based on our case analysis and comprehensive review of existing literature, the co-occurrence of MN and CIDP in anti-CNTN1-positive patients suggests a shared immunopathogenesis, which may require integrated treatment of both conditions. Here, CNTN1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.